+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

  • ID: 5157167
  • Report
  • September 2020
  • Region: Asia Pacific
  • 124 pages
  • GMD Research
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • Abacus Diagnostica Oy
  • Biocartis Group NV
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • QuantuMDx Group Ltd.
  • MORE
Asia Pacific PoC molecular diagnostics market will grow by 15.1% annually with a total addressable market cap of $8,360.1 million over 2020-2030 owing to the rising adoption of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.

Highlighted with 34 tables and 52 figures, this 124-page report “Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Kits & Assays
  • Analyzers & Instruments
  • Software & Services
Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Polymerase Chain Reaction (PCR)
  • Real-Time PCR (rt-PCR)
  • Digital PCR (d-PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Genetic Sequencing-based Technology
  • Microarray-based Technology
  • Other Technologies
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Infectious Disease
  • Respiratory Infections
  • Hospital Acquired Infections
  • Sexually Transmitted Infections
  • Gastrointestinal Infections
  • Oncology
  • Hepatitis
  • Prenatal/Neonatal Testing
  • Other Applications
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Hospitals
  • Clinics & Diagnostic Centers
  • Research and Academic Institutes
  • Other End Users
Geographically, the following national/local markets are fully investigated:
  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific PoC molecular diagnostics market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Alere Inc.
  • Biocartis Group NV
  • Biomerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A
  • DxNA LLC.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Mesa Biotech Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Quidel Corporation
  • Spartan Biosciences Inc.
  • Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abacus Diagnostica Oy
  • Biocartis Group NV
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • QuantuMDx Group Ltd.
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Product
3.1 Market Overview by Product
3.2 Kits & Assays
3.3 Analyzers & Instruments
3.4 Software & Services

4 Segmentation of Asia Pacific Market by Technology
4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
4.2.1 Real-Time PCR (rt-PCR)
4.2.2 Digital PCR (d-PCR)
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.4 Genetic Sequencing-based Technology
4.5 Microarray-based Technology
4.6 Other Technologies

5 Segmentation of Asia Pacific Market by Application
5.1 Market Overview by Application
5.2 Infectious Disease
5.2.1 Respiratory Infections
5.2.2 Hospital Acquired Infections
5.2.3 Sexually Transmitted Infections
5.3 Gastrointestinal Infections
5.4 Oncology
5.5 Hepatitis
5.6 Prenatal/Neonatal Testing
5.7 Other Applications

6 Segmentation of Asia Pacific Market by End User
6.1 Market Overview by End User
6.2 Hospitals
6.3 Clinics & Diagnostic Centers
6.4 Research and Academic Institutes
6.5 Other End Users

7 Asia-Pacific Market 2019-2030 by Country
7.1 Overview of Asia-Pacific Market
7.2 Japan
7.3 China
7.4 Australia
7.5 India
7.6 South Korea
7.7 Rest of APAC Region

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Alere Inc.
  • Biocartis Group NV
  • Biomerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A
  • DxNA LLC.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Mesa Biotech Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Quidel Corporation
  • Spartan Biosciences Inc.
  • Thermo Fisher Scientific
9 Investing in Asia Pacific Market: Risk Assessment and Management
9.1 Risk Evaluation of Asia Pacific Market
9.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Point of Care (PoC) Molecular Diagnostics Market
Table 4. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 5. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 6. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn
Table 7. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 8. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn
Table 9. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn
Table 10. APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 11. Japan Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 12. Japan Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 13. Japan Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 14. China Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 15. China Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 16. China Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 17. Australia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 18. Australia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 19. Australia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 20. India Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 21. India Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 22. India Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 23. South Korea Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 24. South Korea Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 25. South Korea Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 26. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC by Country, 2019-2030, $ mn
Table 27. Breakdown of Asia Pacific Market by Key Vendor, 2019, %
Table 28. Abacus Diagnostica Oy: Company Snapshot
Table 29. Abacus Diagnostica Oy: Business Segmentation
Table 30. Abacus Diagnostica Oy: Product Portfolio
Table 31. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn
Table 32. Abacus Diagnostica Oy: Recent Developments
Table 33. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030
Table 34. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market
Figure 8. World Number of Deaths by Cause in 2017
Figure 9. World Number of Deaths from Cancers in 2017
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market
Figure 13. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn
Figure 16. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn
Figure 17. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn
Figure 18. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue
Figure 19. Asia Pacific Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%)
Figure 20. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn
Figure 21. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn
Figure 22. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn
Figure 23. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn
Figure 24. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn
Figure 25. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn
Figure 26. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn
Figure 27. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue
Figure 28. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 29. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn
Figure 30. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn
Figure 31. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn
Figure 32. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn
Figure 33. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn
Figure 34. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn
Figure 35. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn
Figure 36. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn
Figure 37. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn
Figure 38. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue
Figure 39. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 40. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn
Figure 41. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn
Figure 42. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn
Figure 43. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn
Figure 44. Breakdown of APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 45. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 46. Point of Care (PoC) Molecular Diagnostics Market in Japan, 2019-2030, $ mn
Figure 47. Point of Care (PoC) Molecular Diagnostics Market in China, 2019-2030, $ mn
Figure 48. Point of Care (PoC) Molecular Diagnostics Market in Australia, 2019-2030, $ mn
Figure 49. Point of Care (PoC) Molecular Diagnostics Market in India, 2019-2030, $ mn
Figure 50. Point of Care (PoC) Molecular Diagnostics Market in South Korea, 2019-2030, $ mn
Figure 51. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC, 2019-2030, $ mn
Figure 52. Growth Stage of Asia Pacific Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period
Note: Product cover images may vary from those shown
3 of 4
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Alere Inc.
  • Biocartis Group NV
  • Biomerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A
  • DxNA LLC.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Mesa Biotech Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Quidel Corporation
  • Spartan Biosciences Inc.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll